Multicenter evaluation of the VITROS Anti-HBs assay in immunized patients and patients with signs and symptoms of hepatitis

Multicenter outcomes-based evaluation of the Vitros Immunodiagnostic products anti-HBs reagent pack and calibrators in immunized patients and patients with signs and symptoms of hepatitis. Clinical Chemistry 47(S6): A98-A99, June, 2001

Multicenter outcomes-based evaluation of the Vitros Immunodiagnostic products Anti-HCV reagent pack and calibrator in patients with signs and symptoms of hepatitis and in patients at risk for hepatitis C infection. Hepatology 34(4 Pt 2): 231A, October, 2001

Multicenter evaluation of the Vitros Immunodiagnostic products HBsAg reagent pack and calibrator and the Vitros Immunodiagnostic products HBsAg Confirmatory Kit in patients with signs and symptoms of hepatitis or at risk for viral hepatitis. Clinical Chemistry 47(S6): A99, June, 2001

Performance evaluation of the Vitros anti-hepatitis C virus antibody assay for use in clinical laboratories. Clinical Biochemistry 45(1-2): 175-177, 2012

An evaluation of the Vitros ECi N-telopeptide assay in cancer patients with metastatic disease to bone. Clinical Chemistry 47(S6): A124, June, 2001

Predominantly gastrointestinal symptoms and signs in 11 consecutive AIDS patients with gastrointestinal lymphoma: a multicenter, multiyear study including 763 HIV-seropositive patients. American Journal of Gastroenterology 89(4): 545-549, 1994

Predominantly gastrointestinal symptoms and signs in 11 consecutive AIDS patients with gastrointestinal lymphoma A case controlled, multicenter, multiyear study of 763 HIV seropositive patients. Gastroenterology 106(4 SUPPL ): A659, 1994

Multicenter evaluation of the elecsysA anti-HCV II assay for the diagnosis of hepatitis C virus infection. 2013

Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/American College of Cardiology recommended cutoff values. American Journal of Clinical Pathology 120(1): 114-120, 2003

Evaluation of commercially available third-generation anti-hepatitis C virus enzyme-linked immunosorbent assay in patients on haemodialysis. Indian Journal of Medical Microbiology 25(2): 140-142, 2007

Prospective multicenter trial of capsule endoscopy in patients with chronic abdominal pain, diarrhea and other signs and symptoms (CEDAP-Plus Study). Endoscopy 39(7): 606-612, 2007

Evaluation of the VITROS Chemistry Products rheumatoid factor assay on the VITROS 5,1 FS Chemistry System. Clinical Chemistry 50(6, Suppl S, Part 2): A54-A55, June, 2004

Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome. Journal of Otolaryngology 29(1): 28-34, 2000

Laboratory evaluation of the variation in the vitros EG anti-hepatitis C antibody signal to cutoff ratio and its correlation with HCV RNA positivity. 2007